BEAM – beam therapeutics inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

BEAM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/26

11:34 am

BEAM

Rating for BEAM

Low Report

Rating for BEAM

Report

3/26

11:34 am

BEAM

Rating for BEAM

Low Report

Rating for BEAM

Report

2/25

10:10 am

BEAM

Rating for BEAM

High Report

Rating for BEAM

Report

2/25

10:10 am

BEAM

Rating for BEAM

High Report

Rating for BEAM

Report

2/25

08:23 am

BEAM

Rating for BEAM

Medium Report

Rating for BEAM

Report

2/25

08:23 am

BEAM

Rating for BEAM

Medium Report

Rating for BEAM

Report

2/20

03:50 pm

BEAM

Rating for BEAM

Low Report

Rating for BEAM

Report

2/20

06:51 am

BEAM

Beam Therapeutics initiated with a Buy at Canaccord

Medium Report

Beam Therapeutics initiated with a Buy at Canaccord

Report

2/20

06:29 am

BEAM

Beam Therapeutics initiated with a Buy at Canaccord

Low Report

Beam Therapeutics initiated with a Buy at Canaccord

Report

1/21

10:11 am

BEAM

Rating for BEAM

Low Report

Rating for BEAM

Report

1/21

10:11 am

BEAM

Rating for BEAM

Low Report

Rating for BEAM

Report

1/20

07:09 pm

BEAM

Beam Therapeutics (NASDAQ:BEAM) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.

Low Report

Beam Therapeutics (NASDAQ:BEAM) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.